SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Brand Engagement Network, Inc. engages in the provision of conversational artificial intelligence assistants with the purpose of transforming engagement and analytics for businesses through security-focused, multimodal communication and human-like artificial intelligence assistants. The firm is also involved in delivering highly personalized, multi-modal artificial intelligence engagement with a focus on industries where there is a massive workforce gap and an opportunity to transform how consumers engage with networks, providers, and brands. The company is founded on March 14, 2024 and is headquartered in Jackson, WY.

Brand Engagement Network Inc

Brand Engagement Network Inc. (BNAI) is trending with explosive momentum, primarily fueled by a massive short squeeze and excitement surrounding a recently announced strategic deal with Valio Technologies involving an equity investment and revenue sharing. Community discussion highlights remarkable gains and draws comparisons to other AI sector breakouts, with traders debating the potential for continued upside versus the need to secure profits.

Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel therapeutic platforms, MyMD-1 and SUPERA-CBD, which aim to treat the causes of disease rather than just addressing the symptoms. MyMD-1 is a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cytokines. SUPERA-CBD is a synthetic derivative of cannabidiol being developed to treat conditions such as epilepsy, chronic pain, depression, as well as neuroinflammatory and neurodegenerative diseases. The company was founded in 1989 and is headquartered in New York, NY.

Q/C Technologies Inc.

Q/C Technologies (QCLS) is sparking considerable community buzz following the appointment of an OpenAI expert to its board, validating its strategic pivot into quantum-class computing. This development, coupled with its innovative photonic technology, has ignited strong bullish sentiment among investors who anticipate significant short covering and a potential explosive run.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending due to recent significant share purchases by CEO Ryan Cohen, coupled with strong anticipation for a new GME-focused publication from Michael Burry expected early next week. The community is buzzing with short squeeze speculation, closely watching weekend developments and "power hour" price action, with many believing current movements are setting the stage for a significant upward move.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

United States Antimony Corp (UAMY) is trending strongly amid escalating interest in critical minerals, driven by recent institutional accumulation, notably by the State of Alaska, and the strategic acquisition of a new flotation facility. The community is actively discussing potential government partnerships and UAMY's crucial role as a domestic antimony producer, vital for national security and reducing reliance on foreign supply chains.

Vista Energy SAB de CV is an oil and gas company, which engages in the exploration and production of oil and gas. It operates through Argentina and Mexico geographical segments. The firm's assets include Vaca Muerta, the largest shale oil and gas play under development outside North AMerica. The company was founded by Miguel Galuccio, Pablo Manuel Vera Pinto, Juan Garoby and Alejandro Chernacov on March 22, 2017 and is headquartered in Alcaldía Miguel Hidalgo, Mexico.

Vista Energy S.A.B. de C.V - ADR

Vista Oil & Gas 

Vista Oil & Gas is trending due to its robust operational and financial performance, showcased by significant production growth and strong earnings results. This has led to multiple analyst upgrades and heightened community discussion around its attractive valuation and strategic positioning in the Vaca Muerta shale region. Investors are highlighting its expanding scale and potential as a compelling energy play.

Clearpoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The firm conducts its procedures under direct, intra-procedural magnetic resonance imaging guidance. Its product platform consists of the ClearPoint system and ClearTrace system. The company was founded by Paul A. Bottomley on March 12, 1998 and is headquartered in Solana Beach, CA.

ClearPoint Neuro Inc

ClearPoint Neuro is trending following its recent EU MDR certification for navigation software and the market's excitement over partner UniQure's positive Huntington's disease trial results, which showcased CLPT's essential precision delivery technology. The community is widely discussing CLPT's "gold standard" position in enabling gene therapy to the brain, with expectations for substantial growth as its numerous biopharma collaborations progress through late-stage clinical trials for various neurological conditions.

Ankr is a Web3 decentralized infrastructure provider that helps developers, dapps, and stakers easily interact with multiple blockchains. It allows you to create DApps using API and RPC, staking on Ankr Earn, and use customized blockchain solutions for businesses.

Ankr Network

ANKR is trending amidst widespread community frustration and accusations of being a 'scam' due to its prolonged underperformance, even as many other cryptocurrencies see significant gains. While a large portion of the community expresses disillusionment over its historical price action and perceived lack of utility, a dedicated group of holders continues to champion its foundational Web3 infrastructure and upcoming developments like the Neura L1 blockchain, fueling a highly polarized discussion.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is facing heightened volatility as regulatory actions against prediction markets emerge, with a Massachusetts injunction against Kalshi's sports contracts seen as a potential positive catalyst for traditional sportsbooks. This development, alongside other states considering similar bans, is driving intense community debate against a backdrop of increasing competition and the NCAA's push for a federal college sports betting halt. Investors are closely watching how these evolving market dynamics, coupled with upcoming earnings, will impact the company's trajectory.

Direxion Shares ETF Trust - Direxion Daily Gold Miners Index Bull 2X Shares

Direxion Daily Gold Miners Index Bull 2X Shares

Direxion Daily Gold Miners Index Bull 2X Shares (NUGT) is driving significant conversation as gold approaches record highs amid persistent geopolitical tensions and economic uncertainty, fueling its appeal as a hedge against currency debasement and rising national debt. Bulls foresee substantial gains for miners, anticipating continued upside, while bears warn of overbought conditions and a looming correction, urging caution with this leveraged instrument.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is a top trending stock as the market eagerly awaits the upcoming release of three-year functional results from its pivotal EMBARK study for ELEVIDYS. Community sentiment suggests this pre-announcement signals highly anticipated positive data, sparking widespread discussion about a significant short squeeze and potential long-term value re-rating, including acquisition speculation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Statera Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. Its proprietary product toll-like receptor (TLR) agonists in the biopharmaceutical industry with TLR4 and TLR9 antagonists, and the TLR5 agonists, Entolimod and GP532 have applications in mitigation of radiation injury and neutropenia an anemia. The firm is developing therapies designed to directly elicit within patients a robust and durable response of antigen-specific killer T-cells and antibodies, thereby activating essential immune defenses against autoimmune, inflammatory, infectious diseases, and cancers. It has clinical programs for Crohn’s disease (STAT-201), hematology (Entolimod), pancreatic cancer (STAT-401) and COVID-19 (STAT-205) in addition to expansion into fibromyalgia and multiple sclerosis. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Fort Collins, CO.

Statera BioPharma Inc

$MSFT

$AAPL

$TSLA

$META

Earnings season is heating up, and several major companies report next week, including Microsoft, Apple, Tesla, and Meta. Which are you most excited for?

Which earnings report are you most excited for next week? 
 
Drop a comment for others.

Current Price	$0.0001
Prev Close	$0.0001
Open	$0.0001
Dividend Yield	N/A
50-Day Moving Average	$0.0001
Beta	-214.75
Avg. Volume	29,027.00
PE Ratio	N/A

52-Week High	$0.0133
52-Week Low	$0.00
Market Capitalization	$7,142.00
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

STAB
Statera BioPharma Inc

Feed

News

Sentiment

Fundamentals

Info

Latest STAB News

STABStatera BioPharma Inc